CLONIDINE HYDROCHLORIDE

Post-LOE

clonidine hydrochloride

Teva

ANDAORALTABLET, EXTENDED RELEASE

Approved

May 2015

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

CLONIDINE HYDROCHLORIDE (clonidine hydrochloride) by Teva is 12. Approved for attention deficit hyperactivity disorder (adhd), adjunctive therapy to stimulant medications [see ], adjunctive therapy to stimulant medications. First approved in 2015.

Drug data last refreshed 20h ago

Mechanism of Action

12.1 Mechanism of Action Clonidine stimulates alpha 2 -adrenergic receptors in the brain. Clonidine is not a central nervous system stimulant. The mechanism of action of clonidine in ADHD is not known. 12.2 Pharmacodynamics Clonidine is a known antihypertensive agent. By stimulating alpha 2…

Worked on CLONIDINE HYDROCHLORIDE at Teva? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

CLONIDINE HYDROCHLORIDE

Mechanism of Action

Indications (2)